| Study | Reason for exclusion |
|---|---|
| Bergstrom 1968 | Short duration: antibiotic treatment after randomisation was only 50 days |
| Bose 1974 | Wrong intervention: acute treatment of two types of antibiotics followed by nitrofurantoin prophylaxis i.e. no prophylactic control group |
| Clemente 1994 | Wrong intervention: pidotimod, an immunostimulant agent, plus antibiotics versus placebo for 60 days |
| Craig 2002 | Wrong population: > 50% of children had VUR |
| Espino Hernandez 2012 | Wrong population: > 50% of children had VUR |
| Feldman 1975 | Short duration: 4 week "short term" TMP/SMX versus SMX |
| Fennell 1980 | Short duration: 10 day treatment of ampicillin versus cotrimoxazole versus cephalexin |
| Fischbach 1989 | Short duration: acute treatment for 2 weeks |
| Garin 2006 | Wrong population: 52% of participants had VUR, our inclusion criteria is < 50% with VUR |
| Habeeb Abid 2015 | Wrong population: > 50% children had VUR |
| Hari 2015 | Wrong population: > 50% children had VUR |
| Lee 2007a | Wrong population: all children had VUR |
| Lindberg 1978 | Short duration: acute treatment study; treatment consisted of nitrofurantoin for 10 days, only received 6 month treatment if they had 2 recurrences |
| Madsen 1973 | Wrong population/short duration: cotrimoxazole versus methacycline for 14 days in mostly adults |
| Marild 2009 | Short duration: acute treatment study |
| Mohseni 2013 | Wrong population: > 50% of children had VUR |
| Montini 2007 | Short duration: acute treatment study |
| Pennesi 2008 | Wrong population: all children have VUR |
| Pisani 1982 | Short duration: acute treatment for 10 days |
| Ray 1970 | Wrong population: > 50% of participants had neurogenic/renal abnormalities |
| RIVUR 2008 | Wrong population: > 50% of participants had VUR |
| Roussey‐Kesler 2008 | Wrong population: all children have VUR |
| Sanchez‐Bayle 1983 | Wrong population: > 50% of participants had VUR |
| Swedish Reflux 2010 | Wrong population: > 50% of participants had VUR |
| Zegers 2011 | Wrong population: children with urological and urological abnormality, spina bifida |
SMX ‐ sulphamethoxazole; TMP ‐ trimethoprim; VUR ‐ vesicoureteric reflux